查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829373

2025年全球呼吸吸入設備市場報告

Respiratory Inhaler Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，呼吸吸入設備市場呈現強勁成長勢頭，市場規模從2024年的413.5億美元成長至2025年的439.8億美元，複合年成長率達6.4%。過去的成長主要歸因於吸菸盛行、過敏性疾病、藥物創新和人口老化等因素。

預計未來幾年呼吸吸入設備市場規模將強勁成長，到2029年將達到591.1億美元，複合年成長率為7.7%。預測期內的成長可歸因於空氣品質問題、數位健康整合、對吸入器安全性的監管關注以及個人化治療。預測期內的主要趨勢包括吸入器設備的小型化、永續性和環保吸入器、居家照護以及技術進步。

呼吸吸入裝置是一種緊湊的手持式工具，旨在將藥物直接輸送至肺部。它們專門設計用於將藥物輸送至呼吸系統（主要透過肺部），最大限度地減少全身藥物效應，並在呼吸道疾病發作和加重期間提供快速緩解。

呼吸吸入器產品的主要類別包括乾粉吸入器 (DPI)、定量噴霧吸入器和霧化器。乾粉吸入器是一種將粉末藥物直接輸送到肺部以治療呼吸系統疾病的醫療設備。這些吸入器有手動和電子兩種形式。 DPI 通常用於治療氣喘、慢性阻塞性肺病(COPD)、肺動脈高血壓和其他呼吸系統疾病。呼吸吸入器設備用於各種醫療保健場所，包括醫院、診所、呼吸照護中心和其他醫療機構。它們已成為實施呼吸治療和管理呼吸系統疾病的重要工具。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供呼吸吸入設備市場統計數據，其中包含您在呼吸吸入設備行業取得成功所需的所有數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的呼吸吸入設備細分市場、市場趨勢和商機。本呼吸吸入設備市場研究報告對該行業的現狀和未來走勢進行了詳細分析，以全面的觀點為您提供所需的所有資訊。

我們對該市場未來五年7.7%的成長率預測與先前的預測一致。下降的主要原因是美國與其他國家之間關稅的影響。這種影響可能會對美國產生直接影響，導致計量閥組件和乾粉分散裝置的成本上升（這些產品主要從英國和瑞士進口），從而導致氣喘和慢性阻塞性肺病(COPD) 治療藥物的價格上漲。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

呼吸系統疾病的發生率正在上升，這將推動呼吸吸入設備市場的成長。呼吸系統疾病包括影響肺部和呼吸系統的多種疾病，常常導致呼吸困難和肺功能下降。這些疾病包括氣喘、慢性阻塞性肺病(COPD)、呼吸道融合細胞病毒感染疾病和各種其他呼吸系統疾病。呼吸吸入裝置的使用對於將藥物直接輸送到肺部並為與呼吸系統疾病作鬥爭的人們提供快速準確的緩解至關重要。例如，美國著名公共衛生組織疾病管制與預防中心最近的數據顯示，美國報告的結核病病例預計將從 2021 年的 7,874 例增加到 2022 年的 8,300 例。這些數據凸顯了呼吸系統疾病發病率不斷上升帶來的巨大動力，這將推動呼吸吸入設備市場的擴張。

預計吸煙率上升將在未來幾年推動呼吸吸入設備市場的成長。吸菸包括吸入和呼出燃燒菸草和其他物質產生的蒸氣，會損害肺部的氣道和微小氣囊（肺泡），可能導致氣喘、慢性阻塞性肺病和支氣管炎等呼吸系統疾病。呼吸吸入裝置對於緩解症狀和防止進一步呼吸困難來控制這些疾病至關重要。例如，2024 年 9 月，美國政府機構疾病管制與預防中心 (CDC) 報告稱，菸草使用仍然是美國可預防疾病和死亡的主要原因。到 2022 年，約有 4,920 萬成年人（19.8%）或近五分之一的人報告使用菸草製品。因此，吸煙率上升正在推動呼吸吸入設備市場的成長。

呼吸吸入設備市場的主要企業正擴大採用定量噴霧吸入器(MDI) 等先進技術來鞏固其市場地位。 MDI 是一種攜帶式氣霧劑設備，旨在以吸入霧或噴霧的形式向肺部輸送精確的藥物劑量。例如，2022 年 2 月，專門生產消費者分配包裝和藥物傳輸設備的美國製造商 AptarGroup Inc. 推出了 HeroTracker Sense。這種創新的數位呼吸健康解決方案有效地將傳統的定量噴霧吸入器(pMDI) 轉變為智慧互聯的醫療設備。 HeroTracker Sense 監測患者對 MDI 的使用情況，促進更好地遵守配方治療，並最終改善全球與氣喘、慢性阻塞性肺病(COPD)、囊腫纖維化和 COVID-19 引起的呼吸系統併發症等慢性呼吸系統疾病作鬥爭的個人的生活。 HeroTracker Sense 也透過 Aptar Pharma Cohero Health BreatheSmart Connect 入口網站為醫療保健提供者 (HCP) 提供有關患者培訓、入職和績效的寶貴分析和見解。

2022年8月，總部位於美國、專注於消費性藥品包裝和藥物輸送設備的製造商AptarGroup Inc.透過收購Pharmaxis Ltd.，獲得了Orbital Inhaler的全球權利。此次對Orbital Inhaler權利的策略性收購，與Aptar Pharma的使命相契合，即擴展其呼吸設備產品組合，並為呼吸系統疾病患者提供創新解決方案。 Pharmaxis Ltd.是一家總部位於澳洲、專注於臨床階段的製藥公司，開發了突破性的Orbital Dry Powder Inhaler。這項策略性收購彰顯了Aptar Pharma致力於推進呼吸照護的決心。

呼吸吸入設備市場由提供諸如管理慢性肺部疾病和最大程度減輕藥物全身影響等服務的營業單位所賺取的收益構成。市場規模還包括服務提供者銷售或包含在其服務產品中的相關產品的價值。呼吸吸入設備市場還包括壓縮空氣霧化器、超音波霧化器和網狀霧化器的銷售。該市場的價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球呼吸吸入設備：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球呼吸吸入設備市場：成長率分析
  • 全球呼吸吸入設備市場表現：規模與成長，2019-2024
  • 全球呼吸吸入設備市場預測：規模與成長，2024-2029年，2034年
  • 全球呼吸吸入設備：總目標市場（TAM）

第6章 市場細分

  • 全球呼吸吸入設備市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 乾粉吸入器
  • 定量噴霧吸入器
  • 噴霧器
  • 全球呼吸吸入設備市場技術、效能及預測（2019-2024、2024-2029、2034）
  • 手動吸入器
  • 數位吸入器
  • 全球呼吸吸入設備市場（依疾病適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 氣喘
  • 慢性阻塞性肺病
  • 肺動脈高血壓
  • 其他
  • 全球呼吸吸入設備市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 呼吸護理中心
  • 其他
  • 全球呼吸吸入器設備市場：乾粉吸入器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單劑量吸入器
  • 多劑量吸入器
  • 全球呼吸吸入器設備市場：定量噴霧吸入器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 含氯氟烴的MDI
  • 基於HFA的MDI
  • 全球呼吸吸入設備市場：霧化器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 噴射霧化器
  • 超音波霧化器
  • 網狀霧化器

第7章 區域和國家分析

  • 全球呼吸吸入設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球呼吸吸入設備市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 呼吸吸入器市場：競爭格局
  • 呼吸吸入設備市場：公司簡介
    • Merck & Co. Inc.
    • Novartis AG
    • AstraZeneca plc
    • Gerresheimer AG
    • GlaxoSmithKline plc

第31章：其他領先和創新企業

  • 3M
  • Boehringer Ingelheim International GmbH
  • Koninklijke Philips NV
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • Perrigo Company plc
  • AptarGroup Inc.
  • Recipharm AB
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • Hikma Pharmaceuticals plc
  • Zydus Lifesciences Limited
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年呼吸吸入設備市場：提供新機會的國家
  • 2029年呼吸吸入設備市場：細分市場帶來新機會
  • 2029年呼吸吸入設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r28885u

Respiratory inhaler devices are compact, handheld tools designed to administer medication directly to the lungs. They are specifically engineered to deliver medications to the respiratory system, with a focus on the lungs, which helps minimize systemic drug effects and provides rapid relief during respiratory attacks or exacerbations.

The primary categories of respiratory inhaler device products include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers (DPIs) are medical devices that dispense powdered medications directly to the lungs for the treatment of respiratory conditions. These inhaler devices encompass both manually operated and digitally operated options. They are commonly used in the management of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension, and other respiratory issues. Respiratory inhaler devices find application in various healthcare settings, including hospitals, clinics, respiratory care centers, and other medical facilities. They serve as important tools for the delivery of respiratory medications and the management of respiratory conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The respiratory inhaler devices market research report is one of a series of new reports from The Business Research Company that provides respiratory inhaler devices market statistics, including respiratory inhaler devices industry global market size, regional shares, competitors with a respiratory inhaler devices market share, detailed respiratory inhaler devices market segments, market trends and opportunities and any further data you may need to thrive in the respiratory inhaler devices industry. This respiratory inhaler devices market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The respiratory inhaler devices market size has grown strongly in recent years. It will grow from $41.35 billion in 2024 to $43.98 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to smoking epidemic, allergic disorders, pharmaceutical innovation, aging population.

The respiratory inhaler devices market size is expected to see strong growth in the next few years. It will grow to $59.11 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to air quality concerns, digital health integration, regulatory emphasis on inhaler safety, personalized treatment. Major trends in the forecast period include inhaler device miniaturization, sustainability and eco-friendly inhalers, home-based care, technological advancements.

The forecast of 7.7% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased costs for metered-dose valve assemblies and dry powder dispersion mechanisms, primarily imported from the UK and Switzerland, leading to higher prices for asthma and chronic obstructive pulmonary disease (COPD) treatments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The prevalence of respiratory diseases is on the rise, and this phenomenon is poised to steer the growth of the respiratory inhaler devices market. Respiratory diseases encompass a spectrum of disorders that affect the lungs and the respiratory system, often resulting in breathing difficulties and compromised lung function. These conditions include ailments like asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection, and various other respiratory disorders. The utilization of respiratory inhaler devices is essential in delivering medications directly to the lungs, providing swift and precise relief for individuals battling respiratory illnesses. As an example, recent data from the Centers for Disease Control and Prevention, a prominent US-based public health organization, revealed an increase in tuberculosis (TB) cases reported in the United States, reaching 8,300 cases in 2022, up from 7,874 cases in 2021. This data underscores the significant impetus resulting from the growing prevalence of respiratory diseases, which propels the expansion of the respiratory inhaler devices market.

The rising smoking rates are expected to drive the growth of the respiratory inhaler devices market in the coming years. Smoking, which involves inhaling and exhaling the vapors of burning tobacco or other substances, can damage the airways and small air sacs (alveoli) in the lungs, leading to respiratory diseases such as asthma, COPD, and bronchitis. Respiratory inhaler devices are crucial for managing these conditions by alleviating symptoms and preventing further breathing difficulties. For instance, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that tobacco use remains the leading cause of preventable disease and death in the United States. In 2022, about 49.2 million adults, or 19.8%, nearly 1 in 5, reported using tobacco products. As a result, the increasing smoking rates are driving the growth of the respiratory inhaler devices market.

Prominent companies within the respiratory inhaler devices market are increasingly adopting advanced technologies, such as metered dosage inhalers (MDIs), to fortify their market standing. MDIs represent portable aerosol devices designed to deliver precise medication doses to the lungs in the form of an inhaled mist or spray. For instance, a noteworthy development occurred in February 2022, when AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital respiratory health solution effectively transforms conventional metered dosage inhalers (pMDIs) into intelligent and connected medical devices. HeroTracker Sense aims to monitor the utilization of MDIs by patients, promoting better adherence to prescribed therapies and ultimately enhancing the lives of individuals worldwide grappling with chronic respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory complications triggered by COVID-19. HeroTracker Sense further offers invaluable analytics and insights related to patient training, onboarding, and performance, serving healthcare providers (HCPs) through the Aptar Pharma Cohero Health BreatheSmart Connect portal.

In August 2022, AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, secured the global rights to the Orbital inhaler through an acquisition from Pharmaxis Ltd. This strategic acquisition of the Orbital inhaler rights aligns with Aptar Pharma's mission to expand its respiratory device portfolio and provide innovative solutions catering to patients grappling with respiratory conditions. Pharmaxis Ltd., an Australian-based pharmaceutical company with a clinical-stage focus, developed the groundbreaking Orbital dry powder inhaler. This strategic acquisition demonstrates a commitment to advancing respiratory care.

Major companies operating in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.

North America was the largest region in the respiratory inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the respiratory inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory inhaler devices market consists of revenues earned by entities by providing services such as the management of chronic lung diseases and minimizing systemic effects of the drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory inhaler devices market also includes sales of compressed air nebulizers, ultrasonic nebulizers and mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Inhaler Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory inhaler devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory inhaler devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Technology: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Disease Indication: Asthma; Chronic Obstructive Pulmonary Disease; Pulmonary Arterial Hypertension; Other Indications
  • 4) By End User: Hospitals And Clinics; Respiratory Care Centers; Other End Users
  • Subsegments:
  • 1) By Dry Powder Inhalers: Single-Dose Inhalers; Multi-Dose Inhalers
  • 2) By Metered Dose Inhalers: CFC-Based MDIs; HFA-Based MDIs
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Merck & Co. Inc.; Novartis AG; AstraZeneca plc; Gerresheimer AG; GlaxoSmithKline plc; 3M; Boehringer Ingelheim International GmbH; Koninklijke Philips N.V.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Catalent Inc.; Perrigo Company plc; AptarGroup Inc.; Recipharm AB; Chiesi Farmaceutici S.p.A.; Cipla Limited; Hikma Pharmaceuticals plc; Zydus Lifesciences Limited; Lupin Limited; Glenmark Pharmaceuticals Ltd.; Orion Corporation; Sumitomo Pharma America Inc.; Beximco Pharmaceuticals Ltd.; Hovione Limited; Vectura Group Limited; H&T Presspart Manufacturing Ltd.; Pari Medical Holding GmbH; OMRON Healthcare Europe B.V.; Medisol Lifescience Pvt. Ltd.; Consort Medical plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Inhaler Devices Market Characteristics

3. Respiratory Inhaler Devices Market Trends And Strategies

4. Respiratory Inhaler Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Inhaler Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Inhaler Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Inhaler Devices Market Growth Rate Analysis
  • 5.4. Global Respiratory Inhaler Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Inhaler Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Inhaler Devices Total Addressable Market (TAM)

6. Respiratory Inhaler Devices Market Segmentation

  • 6.1. Global Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Other Indications
  • 6.4. Global Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Respiratory Care Centers
  • Other End Users
  • 6.5. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Inhalers
  • Multi-Dose Inhalers
  • 6.6. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CFC-Based MDIs
  • HFA-Based MDIs
  • 6.7. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

7. Respiratory Inhaler Devices Market Regional And Country Analysis

  • 7.1. Global Respiratory Inhaler Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Inhaler Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Inhaler Devices Market

  • 8.1. Asia-Pacific Respiratory Inhaler Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Inhaler Devices Market

  • 9.1. China Respiratory Inhaler Devices Market Overview
  • 9.2. China Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Inhaler Devices Market

  • 10.1. India Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Inhaler Devices Market

  • 11.1. Japan Respiratory Inhaler Devices Market Overview
  • 11.2. Japan Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Inhaler Devices Market

  • 12.1. Australia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Inhaler Devices Market

  • 13.1. Indonesia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Inhaler Devices Market

  • 14.1. South Korea Respiratory Inhaler Devices Market Overview
  • 14.2. South Korea Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Inhaler Devices Market

  • 15.1. Western Europe Respiratory Inhaler Devices Market Overview
  • 15.2. Western Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Inhaler Devices Market

  • 16.1. UK Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Inhaler Devices Market

  • 17.1. Germany Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Inhaler Devices Market

  • 18.1. France Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Inhaler Devices Market

  • 19.1. Italy Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Inhaler Devices Market

  • 20.1. Spain Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Inhaler Devices Market

  • 21.1. Eastern Europe Respiratory Inhaler Devices Market Overview
  • 21.2. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Inhaler Devices Market

  • 22.1. Russia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Inhaler Devices Market

  • 23.1. North America Respiratory Inhaler Devices Market Overview
  • 23.2. North America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Inhaler Devices Market

  • 24.1. USA Respiratory Inhaler Devices Market Overview
  • 24.2. USA Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Inhaler Devices Market

  • 25.1. Canada Respiratory Inhaler Devices Market Overview
  • 25.2. Canada Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Inhaler Devices Market

  • 26.1. South America Respiratory Inhaler Devices Market Overview
  • 26.2. South America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Inhaler Devices Market

  • 27.1. Brazil Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Inhaler Devices Market

  • 28.1. Middle East Respiratory Inhaler Devices Market Overview
  • 28.2. Middle East Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Inhaler Devices Market

  • 29.1. Africa Respiratory Inhaler Devices Market Overview
  • 29.2. Africa Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Inhaler Devices Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Inhaler Devices Market Competitive Landscape
  • 30.2. Respiratory Inhaler Devices Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Inhaler Devices Market Other Major And Innovative Companies

  • 31.1. 3M
  • 31.2. Boehringer Ingelheim International GmbH
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Viatris Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Catalent Inc.
  • 31.7. Perrigo Company plc
  • 31.8. AptarGroup Inc.
  • 31.9. Recipharm AB
  • 31.10. Chiesi Farmaceutici S.p.A.
  • 31.11. Cipla Limited
  • 31.12. Hikma Pharmaceuticals plc
  • 31.13. Zydus Lifesciences Limited
  • 31.14. Lupin Limited
  • 31.15. Glenmark Pharmaceuticals Ltd.

32. Global Respiratory Inhaler Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Inhaler Devices Market

34. Recent Developments In The Respiratory Inhaler Devices Market

35. Respiratory Inhaler Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Inhaler Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Inhaler Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Inhaler Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer